BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  ULURU Inc. Announces Senior Management Change

  June 7, 2010

   · 

  1 min read
• Drug Development

  ImmunoGen, Inc. Announces Presentation of Clinical Data for Trastuzumab-DM1 at American Society of Clinical Oncology Annual Meeting

  June 7, 2010

   · 

  1 min read
• Drug Development

  Celldex Therapeutics, Inc. Release: Interim Positive Results From Phase 2b Brain Cancer Study With Rindopepimut (PF-04948568 or CDX-110) Presented at 46th Annual American Society of Clinical Oncology Meeting

  June 7, 2010

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: Randomized Phase III Study Comparing REVLIMID(R) Plus Melphalan and Prednisone (MPR) Compared to Autologous Stem Cell Transplant Presented at American Society of Clinical Oncology

  June 7, 2010

   · 

  1 min read
• Drug Development

  Millennium: The Takeda Oncology Company Release: Oral Presentations Showcase Impressive Results of VELCADE(R) (bortezomib) Based Therapy in Multiple Myeloma

  June 7, 2010

   · 

  1 min read
• Drug Development

  Progenics Pharmaceuticals, Inc. Phase 1 PSMA ADC Study Presented in New “Trials in Progress” Poster Session at American Society of Clinical Oncology Annual Meeting

  June 7, 2010

   · 

  1 min read
• Drug Development

  Genentech Release: Phase III Study Showed Avastin-Based Regimen Helped Women with Advanced Ovarian Cancer Live Longer Without Their Disease Worsening

  June 7, 2010

   · 

  1 min read
• Drug Development

  Plexxikon Inc. Release: PLX4032 Phase 1 Extension Data in Colorectal Cancer Reported

  June 7, 2010

   · 

  1 min read
• Pharm Country

  PhotoMedex, Inc. Announces Clinical Trial Using the XTRAC Velocity(R) Laser in the Treatment of Severe Generalized Psoriasis

  June 7, 2010

   · 

  1 min read
• Lone Star Bio

  Opexa Therapeutics to Prepay Convertible Notes Issued in 2009

  June 7, 2010

   · 

  1 min read